bromopyruvate has been researched along with Neuroblastoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cardaci, S; Ciriolo, MR; Da Costa Ferreira, AM; Filomeni, G; Rotilio, G | 1 |
Hashimoto, K; Ide, S; Inoue, M; Koike, Y; Kusunoki, M; Matsushita, K; Otake, K; Saigusa, S; Tanaka, K; Uchida, K | 1 |
2 other study(ies) available for bromopyruvate and Neuroblastoma
Article | Year |
---|---|
Metabolic oxidative stress elicited by the copper(II) complex [Cu(isaepy)2] triggers apoptosis in SH-SY5Y cells through the induction of the AMP-activated protein kinase/p38MAPK/p53 signalling axis: evidence for a combined use with 3-bromopyruvate in neur
Topics: AMP-Activated Protein Kinases; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Mice; Molecular Structure; Neuroblastoma; Neurons; Organometallic Compounds; Oxidative Stress; Oxindoles; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyruvates; Schiff Bases; Tumor Suppressor Protein p53 | 2011 |
Glycolysis inhibitors as a potential therapeutic option to treat aggressive neuroblastoma expressing GLUT1.
Topics: Antineoplastic Agents; Biomarkers, Tumor; Cell Line, Tumor; Chemotherapy, Adjuvant; Child; Child, Preschool; Enzyme Inhibitors; Female; Follow-Up Studies; Glucose Transporter Type 1; Humans; Infant; Ki-67 Antigen; Male; Neuroblastoma; Pyruvates; Real-Time Polymerase Chain Reaction; Survival Analysis; Treatment Outcome | 2012 |